On Wednesday, July 18, 2018, the FDA arrived to conduct their bi-annual general audit.
After spending a week reviewing our SOPs, training records, quality procedures, and much more the audit concluded.
Reed-Lane is proud to announce that we did not receive any 483s!
We are proud to continue our longstanding commitment to quality assurance, which is evident by not receiving any 483s in over 20 years.